Surveillance of Barrett's esophagus: A need for guidelines?

Diseases of the Esophagus

Volumn 10, Issue 3, 1997, Pages 185-189

  Ackroyd, R ^a   Wakefield, S E ^a   Williams, J L ^a   Stoddard, C J ^a   Reed, M W R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER SURGERY; CELL TRANSFORMATION; CLINICAL PROTOCOL; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK;

EID: 0030804304     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1093/dote/10.3.185     Document Type: Article

References (20)

1. Naef A P, Savary M, Ozzello L. Columnar-lined esophagus: an acquired lesion with a malignant predisposition. J Thorac Cardiovasc Surg 1975; 70: 826-834.
2. Cameron A J, Ott B J, Payne W S. The incidence of adenocarcinoma in columnar lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-859.
3. Spechler S J, Robbins A H, Rubins H B et al. Adenocarcinoma and Barrett's esophagus: an over-rated risk. Gastroenterology 1984; 84: 927-933.
4. van der Veen A H, Dees J, Blankensteijn J D, van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: An over-rated risk. Gut 1989; 30: 14-18.
5. Sjogren R W, Johnson L F. Barrett's esophagus: a review. Am J Med 1983; 74:313-321.
6. Hameetman W, Tytgat G N J, Houthoff H J, van den Tweel J G. Barrett's esophagus: development of dysplasia and carcinoma. Gastroenterology 1989; 96: 1249-1256.
7. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991; 32: 1441-1446.
8. Robertson C S, Mayberry J F, Nicholson D A et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75:760-763.
9. Trent Regional Health Authority Handbook 94/95 (NHS Executive).
10. Sprung D J, Ellis F H, Gibb S P. Regression of Barrett's epithelium after anti-reflux surgery (Abstract). Am J Gastroenterol 1984; 79: 817.
11. Atkinson M. Barrett's oesophagus - to screen or not to screen? Gut 1989; 30: 2-5.
12. Streitz J M Jr, Andrews C W Jr, Ellis F H Jr. Endoscopic surveillance of Barrett's esophagus: Does it help? J Thorac Cardiovasc Surg 1993; 105: 383-388.
13. American Cancer Society. Guidelines for the cancer related check-up: recommendations and rationale. Cancer 1980; 80: 194-240.
14. Ackroyd R, Hosie K B, Pollock K et al. Acid suppression does not prevent carcinoma developing in Barrett's oesophagus. Gut 1993;34(Suppl. 1): 52.
15. Peters F T M, Kleibeuker J H. Barrett's oesophagus and carcinoma: Recent insights into its development and possible prevention. Scand J Gastroenterol 1993; 28(Suppl. 200): 59-64.
16. Menke-Pluymers M B E, Hop W C J, Dees J et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett's) esophagus. Cancer 1993; 72: 1155-1158.
17. Harle I A, Finley R J, Belsheim M et al. Management of adenocarcinoma in columnar lined esophagus. Ann Thorac Surg 1985; 40: 330-336.
18. Ransom J M, Patel G R, Cliff S A, Wamble N E, Read R C. Extended and limited types of Barrett's esophagus in the adult. Ann Thorac Surg 1982; 33: 19-27.
19. Hamilton S R, Smith R R L. The relationship between columnar epithelial dysplasia and invasive carcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87: 302-312.
20. Reid B J, Rubin C E. When is the columnar lined esophagus premalignant? Gastroenterology 1985; 88: 1552.